The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 18,176 | 1,111,030 | SH | SOLE | 1,111,030 | 0 | 0 | ||
AFTERNEXT HEALTHTECH ACQUISITION CORP | *W EXP 99/99/999 | G01109126 | 59 | 366,666 | SH | SOLE | 366,666 | 0 | 0 | ||
ALGOMA STL GROUP INC | COM | 015658107 | 23,936 | 3,716,732 | SH | SOLE | 3,716,732 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 17,627 | 1,688,400 | SH | SOLE | 1,688,400 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 18,174 | 266,090 | SH | SOLE | 266,090 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 16,915 | 646,586 | SH | SOLE | 646,586 | 0 | 0 | ||
ARES ACQUISITION CORP | *W EXP 99/99/999 | G33032122 | 58 | 504,706 | SH | SOLE | 504,706 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 10,157 | 28,770 | SH | SOLE | 28,770 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 17,752 | 399,000 | SH | SOLE | 399,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 12,742 | 123,400 | SH | SOLE | 123,400 | 0 | 0 | ||
BERENSON ACQUISITION CORP I | *W EXP 08/01/202 | 083690115 | 44 | 862,499 | SH | SOLE | 862,499 | 0 | 0 | ||
BILANDER ACQUISITION CORP | *W EXP 05/19/202 | 09001T114 | 36 | 183,749 | SH | SOLE | 183,749 | 0 | 0 | ||
BRIDGETOWN HOLDINGS LTD | *W EXP 09/30/202 | G1355U121 | 116 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
CATALYST PARTNERS ACQUISITION | *W EXP 05/12/202 | G19550121 | 37 | 336,666 | SH | SOLE | 336,666 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 15,173 | 536,901 | SH | SOLE | 536,901 | 0 | 0 | ||
CHURCHILL CAPITAL CORP V | *W EXP 10/29/202 | 17144T115 | 52 | 612,000 | SH | SOLE | 612,000 | 0 | 0 | ||
CHURCHILL CAPITAL CORP VI | *W EXP 02/17/202 | 17143W119 | 76 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
CHURCHILL CAPITAL CORP VII | *W EXP 02/29/202 | 17144M110 | 74 | 548,000 | SH | SOLE | 548,000 | 0 | 0 | ||
COHN ROBBINS HOLDINGS CORP | *W EXP 08/28/202 | G23726113 | 21 | 904,000 | SH | SOLE | 904,000 | 0 | 0 | ||
COMPASS DIGITAL ACQUISITION CORP | *W EXP 09/29/202 | G2476C123 | 41 | 459,906 | SH | SOLE | 459,906 | 0 | 0 | ||
CONCORD ACQUISITION CORP II | *W EXP 99/99/999 | 20607U116 | 86 | 408,333 | SH | SOLE | 408,333 | 0 | 0 | ||
CONYERS PARK III ACQUISITION CORP | *W EXP 08/12/202 | 21289P110 | 104 | 571,666 | SH | SOLE | 571,666 | 0 | 0 | ||
CORSAIR PARTNERING CORP | *W EXP 07/06/202 | G2540H116 | 28 | 334,666 | SH | SOLE | 334,666 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 18,449 | 380,793 | SH | SOLE | 380,793 | 0 | 0 | ||
DISH NETWORK CORPORATION | NOTE 12/1 | 25470MAF6 | 13,220 | 20,000,000 | PRN | SOLE | 20,000,000 | 0 | 0 | ||
FIRST LIGHT ACQUISITION GROUP INC | *W EXP 03/14/202 | 320703119 | 37 | 655,200 | SH | SOLE | 655,200 | 0 | 0 | ||
FORTRESS CAPITAL ACQUISITION C | *W EXP 99/99/999 | G36427121 | 31 | 392,000 | SH | SOLE | 392,000 | 0 | 0 | ||
FORTRESS VALUE ACQUISITION COR | *W EXP 12/31/202 | 34964G115 | 23 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
FORTRESS VALUE ACQUISITION COR | *W EXP 03/18/202 | 34964K116 | 54 | 306,513 | SH | SOLE | 306,513 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 16,190 | 379,702 | SH | SOLE | 379,702 | 0 | 0 | ||
GLOBAL BUSINESS TRAVEL GROUP | *W EXP 99/99/9999 | 37890B118 | 1,433 | 913,000 | SH | SOLE | 913,000 | 0 | 0 | ||
GORES TECHNOLOGY PARTNERS II INC | *W EXP 03/16/202 | 38287L115 | 72 | 450,691 | SH | SOLE | 450,691 | 0 | 0 | ||
GORES TECHNOLOGY PARTNERS INC | *W EXP 03/16/202 | 382870111 | 38 | 201,000 | SH | SOLE | 201,000 | 0 | 0 | ||
HEALTH ASSURANCE ACQUISITION C | *W EXP 11/12/202 | 42226W117 | 19 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | ||
HOME PLATE ACQUISITION CORP | *W EXP 09/30/202 | 43734R111 | 17 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 15,194 | 1,586,043 | SH | SOLE | 1,586,043 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 17,718 | 987,600 | SH | SOLE | 987,600 | 0 | 0 | ||
JAWS HURRICANE ACQUISITION CORP | *W EXP 03/26/202 | 47201B111 | 65 | 387,249 | SH | SOLE | 387,249 | 0 | 0 | ||
KKR ACQUISITION HOLDINGS I CORP | *W EXP 99/99/999 | 48253T117 | 71 | 588,547 | SH | SOLE | 588,547 | 0 | 0 | ||
LEVERE HOLDINGS CORP | *W EXP 03/09/202 | G5462L122 | 14 | 274,999 | SH | SOLE | 274,999 | 0 | 0 | ||
MARBLEGATE ACQUISITION CORP | *W EXP 08/31/202 | 56608A113 | 16 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
MUSIC ACQUISITION CORP/THE | *W EXP 02/05/202 | 62752R118 | 3 | 75,250 | SH | SOLE | 75,250 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 18,516 | 305,400 | SH | SOLE | 305,400 | 0 | 0 | ||
REVOLUTION HEALTHCARE ACQUISIT | *W EXP 12/31/202 | 76155Y116 | 17 | 432,639 | SH | SOLE | 432,639 | 0 | 0 | ||
ROSS ACQUISITION CORP II | *W EXP 02/01/202 | G7641C114 | 34 | 439,666 | SH | SOLE | 439,666 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 16,812 | 429,313 | SH | SOLE | 429,313 | 0 | 0 | ||
SENIOR CONNECT ACQUISITION COR | *W EXP 12/31/202 | 81723H116 | 10 | 1,014,000 | SH | SOLE | 1,014,000 | 0 | 0 | ||
SIMON PROPERTY GROUP ACQUISITION HOLDINGS INC | *W EXP 02/04/202 | 82880R111 | 22 | 335,200 | SH | SOLE | 335,200 | 0 | 0 | ||
SKYDECK ACQUISITION CORP | *W EXP 05/13/202 | G82220115 | 42 | 361,756 | SH | SOLE | 361,756 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 8,790 | 308,092 | SH | SOLE | 308,092 | 0 | 0 | ||
STARRY GROUP HOLDINGS INC | *W EXP 99/99/999 | 85572U110 | 87 | 669,000 | SH | SOLE | 669,000 | 0 | 0 | ||
SUMMIT HEALTHCARE ACQUISITION CORP | *W EXP 06/03/202 | G8566R110 | 74 | 489,999 | SH | SOLE | 489,999 | 0 | 0 | ||
SWIFTMERGE ACQUISITION CORP | *W EXP 12/13/202 | G63836111 | 25 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 25,351 | 1,028,875 | SH | SOLE | 1,028,875 | 0 | 0 | ||
WARBURG PINCUS CAPITAL CORP I-A | *W EXP 99/99/999 | G9461D115 | 1 | 14,999 | SH | SOLE | 14,999 | 0 | 0 | ||
WARBURG PINCUS CAPITAL CORP I-B | *W EXP 99/99/999 | G9460M124 | 8 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
ZIMMER ENERGY TRANSITION ACQUISITION CORP | *W EXP 06/16/202 | 989570114 | 111 | 358,270 | SH | SOLE | 358,270 | 0 | 0 |